DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Depakene (Valproic Acid) - Pyrexia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pyrexia (46)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Depakene (Valproic Acid) where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 46   Next >>

Possible Depakene side effects in female

Reported by a physician from China on 2012-08-20

Patient: female

Reactions: Drug Eruption, Anaphylactoid Reaction, Swelling, Pyrexia, Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Penicillin



Possible Depakene side effects in female

Reported by a physician from Japan on 2012-08-15

Patient: female

Reactions: Rash Generalised, Lymphocyte Stimulation Test Positive, Pyrexia, Rash, Drug Rash With Eosinophilia and Systemic Symptoms, Periproctitis, Anal Erosion, Generalised Erythema, Gamma-Glutamyltransferase Increased, Human Herpes Virus 6 Serology Positive, Anal Haemorrhage, White Blood Cell Count Increased, Toxic Skin Eruption

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 1000mg per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2010-05-07

Lamictal
    Dosage: 50mg per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2010-05-10
    End date: 2010-06-25

Other drugs received by patient: Clobazam; Tegretol



Possible Depakene side effects in 77 year old male

Reported by a physician from Japan on 2012-08-13

Patient: 77 year old male

Reactions: Drug Eruption, Abdominal Pain, Pruritus, Extravasation Blood, Pyrexia, Erythema, Liver Disorder, Lymphocytic Infiltration, Malaise, Dermatitis, Injection Site Induration, Adrenal Insufficiency, Mycoplasma Test Positive, Erythema Multiforme, Procalcitonin Increased, Mass, Urinary Tract Infection, Blood Potassium Increased, Rash, Delirium, Pigmentation Disorder, Epidermal Necrosis, Insomnia, Human Herpesvirus 6 Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cefaclor
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Respiratory Tract Infection
    Start date: 2012-04-12

Clarithromycin
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Urinary Tract Infection
    Start date: 2011-11-29
    End date: 2011-12-06

Depakene
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2012-04-18

Keppra
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2012-04-18

Tegretol
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2012-03-16
    End date: 2012-04-17

Other drugs received by patient: Teofurmate; Hokunalin; Cyscarbon; Aspirin; Protecadin; Feburic



Possible Depakene side effects in female

Reported by a physician from Brazil on 2012-08-13

Patient: female, weighing 72.0 kg (158.4 pounds)

Reactions: Pneumonia, Pain, Monocytosis, Ovarian Cyst, Neck Mass, Pyrexia, Eye Pain, Dengue Fever, Rash Macular, Lymphocytosis, Generalised Erythema, Oedema Peripheral, Unevaluable Event, Thyroid Neoplasm, Post Procedural Haemorrhage, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Epilepsy
    End date: 1998-01-01

Depakene
    Administration route: Oral
    Start date: 1998-01-01

Depakene
    Start date: 2009-01-01

Depakene

Other drugs received by patient: Lamotrigine; Phenobarbital TAB; Atenolol; Clonazepam



Possible Depakene side effects in male

Reported by a physician from Japan on 2012-08-07

Patient: male

Reactions: Pyrexia, Eczema, Lymphocyte Stimulation Test Positive, Oral Mucosa Erosion, Stevens-Johnson Syndrome, LIP Erosion

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 500mg per day
    Administration route: Oral
    Indication: Mood Swings
    Start date: 2012-01-23
    End date: 2012-06-22

Lamictal
    Dosage: 12.5mg per day
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2012-05-28
    End date: 2012-06-01

Lamictal
    Dosage: 25mg per day
    Administration route: Oral
    Start date: 2012-06-01
    End date: 2012-06-22

Topiramate
    Dosage: 350mg per day
    Administration route: Oral
    Indication: Post-Traumatic Stress Disorder
    Start date: 2012-01-23
    End date: 2012-06-22



Possible Depakene side effects in female

Reported by a physician from Japan on 2012-08-06

Patient: female, weighing 43.0 kg (94.6 pounds)

Reactions: Dermatitis Contact, Pyrexia, Rash, Erythema, Drug Rash With Eosinophilia and Systemic Symptoms, Eosinophilia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 800mg per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-03-14
    End date: 2011-05-24

Lamictal
    Dosage: 25mg per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-04-05
    End date: 2011-05-24

Other drugs received by patient: Cytotec



Possible Depakene side effects in female

Reported by a physician from France on 2012-08-03

Patient: female

Reactions: Anaemia, Pyrexia, Aplasia Pure RED Cell, Conjunctival Pallor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bactrim
    Dosage: 5ml per day
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-05-24

Depakene
    Dosage: 100mg per day
    Administration route: Oral
    Indication: Encephalopathy
    End date: 2012-05-27

Retrovir
    Dosage: 15ml twice per day
    Administration route: Oral
    Indication: HIV Infection
    End date: 2012-05-24

Other drugs received by patient: Viramune; Epivir; Ursolvan



Possible Depakene side effects in 77 year old male

Reported by a physician from Japan on 2012-07-18

Patient: 77 year old male

Reactions: Drug Eruption, Abdominal Pain, Pruritus, Gram Stain Positive, Extravasation Blood, Pyrexia, Erythema, Liver Disorder, Lymphocytic Infiltration, Malaise, Dermatitis, Injection Site Induration, Adrenal Insufficiency, Mycoplasma Test Positive, Erythema Multiforme, Mass, Urinary Tract Infection, Blood Potassium Increased, Rash, Lymphocyte Stimulation Test Positive, Delirium, Pigmentation Disorder, Epidermal Necrosis, Insomnia, Human Herpesvirus 6 Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cefaclor
    Dosage: unk ukn, unk
    Administration route: Oral
    Start date: 2012-04-12

Clarithromycin
    Dosage: unk ukn, unk
    Administration route: Oral
    Start date: 2011-11-29
    End date: 2011-12-06

Depakene
    Dosage: unk ukn, unk
    Administration route: Oral
    Start date: 2012-04-18

Keppra
    Dosage: unk ukn, unk
    Administration route: Oral
    Start date: 2012-04-18

Tegretol
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2012-03-16
    End date: 2012-04-18

Other drugs received by patient: Protecadin; Cyscarbon; Feburic; Hokunalin; Aspirin; Teofurmate



Possible Depakene side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-13

Patient: 43 year old male

Reactions: Cytolytic Hepatitis, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Toxic Skin Eruption

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Theralene; Pulmicort; Foradil; Loxapine HCL; Ciprofloxacin HCL; Imovane; Ditropan; Tegretol



Possible Depakene side effects in female

Reported by a physician from Japan on 2012-07-10

Patient: female

Reactions: Eye Discharge, Scab, Oropharyngeal Pain, Pyrexia, LIP Erosion, Generalised Erythema, C-Reactive Protein Increased, Dermatitis Bullous, Erythema Multiforme, Monocyte Percentage Increased, Oral Mucosa Erosion, Eosinophil Percentage Increased, Blister, Stevens-Johnson Syndrome, Swelling Face, Erythema of Eyelid, Dysphagia, Vulval Disorder, Pain of Skin, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Toxic Epidermal Necrolysis, Oropharyngeal Discomfort, Epidermal Necrosis, Aspartate Aminotransferase Increased, Ocular Hyperaemia, Skin Erosion, Rash Maculo-Papular

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 200mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-11-01
    End date: 2012-04-30

Depakene
    Dosage: 100mg per day
    Administration route: Oral
    Start date: 2012-05-01
    End date: 2012-05-09

Lamictal
    Dosage: 25mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2012-04-23
    End date: 2012-04-30

Lamictal
    Dosage: 50mg per day
    Administration route: Oral
    Start date: 2012-05-01
    End date: 2012-05-09

Other drugs received by patient: Zoloft; Cymbalta



Possible Depakene side effects in female

Reported by a consumer/non-health professional from Brazil on 2012-07-03

Patient: female, weighing 72.0 kg (158.4 pounds)

Reactions: Pneumonia, Pain, Monocytosis, Ovarian Cyst, Neck Mass, Pyrexia, Rash Macular, Eye Pain, Dengue Fever, Lymphocytosis, Generalised Erythema, Oedema Peripheral, Unevaluable Event, Thyroid Neoplasm, Post Procedural Haemorrhage, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 2 capsules am and 2 at night
    Administration route: Oral
    Indication: Epilepsy

Depakene
    Dosage: 1 capsule am and 2 at night
    Administration route: Oral



Possible Depakene side effects in female

Reported by a pharmacist from Japan on 2012-07-03

Patient: female, weighing 43.0 kg (94.6 pounds)

Reactions: Dermatitis Contact, Pyrexia, Rash, Erythema, Drug Rash With Eosinophilia and Systemic Symptoms, Eosinophilia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 800mg per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-03-14
    End date: 2011-05-24

Lamictal
    Dosage: 25mg per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-04-05
    End date: 2011-05-24

Other drugs received by patient: Cytotec



Possible Depakene side effects in male

Reported by a physician from Japan on 2012-07-02

Patient: male

Reactions: Eyelid Oedema, Lymphadenopathy, Skin Test Positive, Rash, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Erythema, Skin Lesion, Liver Function Test Abnormal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 800mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-11-09
    End date: 2011-05-27

Lamictal
    Dosage: 25mg alternate days
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-04-28
    End date: 2011-05-12

Lamictal
    Dosage: 25mg per day
    Administration route: Oral
    Start date: 2011-05-13
    End date: 2011-05-25

Other drugs received by patient: Chinese Medicine; Magmitt; Rohypnol; Depas



Possible Depakene side effects in female

Reported by a physician from Japan on 2012-06-26

Patient: female

Reactions: Drug Eruption, Lymphadenopathy, Hepatic Function Abnormal, Fibrin Degradation Products Increased, Disseminated Intravascular Coagulation, Blood Albumin Decreased, Pyrexia, Malaise, Blood Fibrinogen Decreased, Fibrin D Dimer Increased, C-Reactive Protein Increased, Decreased Appetite, Blood Alkaline Phosphatase Increased, Viral Infection, Kidney Enlargement, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Blood Cholinesterase Decreased, Protein Total Decreased, Local Swelling, Hepatic Enzyme Increased, Varicella Virus Test Positive, Herpes Simplex Serology Positive, Aspartate Aminotransferase Increased, Platelet Count Decreased, Leucine Aminopeptidase Increased, Meningitis Aseptic

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 600mg per day
    Administration route: Oral
    Indication: Bipolar II Disorder

Lamictal
    Dosage: 25mg twice per day
    Administration route: Oral
    Indication: Bipolar II Disorder
    Start date: 2012-05-07
    End date: 2012-05-23

Other drugs received by patient: Dogmatyl; Risperdal; Desyrel; Clonazepam; Pursennid; Magmitt



Possible Depakene side effects in female

Reported by a pharmacist from Japan on 2012-06-20

Patient: female

Reactions: Drug Eruption, Hepatic Function Abnormal, Lymphadenopathy, Fibrin Degradation Products Increased, Disseminated Intravascular Coagulation, Blood Albumin Decreased, Pyrexia, Blood Fibrinogen Decreased, C-Reactive Protein Increased, Fibrin D Dimer Increased, Blood Alkaline Phosphatase Increased, Viral Infection, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Blood Cholinesterase Decreased, Protein Total Decreased, Local Swelling, Hepatic Enzyme Increased, Varicella Virus Test Positive, Herpes Simplex Serology Positive, Aspartate Aminotransferase Increased, Platelet Count Decreased, Leucine Aminopeptidase Increased, Meningitis Aseptic

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 600mg per day
    Administration route: Oral
    Indication: Bipolar II Disorder

Lamictal
    Dosage: 25mg twice per day
    Administration route: Oral
    Indication: Bipolar II Disorder
    Start date: 2012-05-07
    End date: 2012-05-23

Other drugs received by patient: Clonazepam; Dogmatyl; Pursennid; Risperdal; Magmitt; Desyrel



Possible Depakene side effects in female

Reported by a physician from Japan on 2012-06-12

Patient: female

Reactions: Drug Eruption, Hepatic Function Abnormal, Lymphadenopathy, Fibrin Degradation Products Increased, Disseminated Intravascular Coagulation, Blood Albumin Decreased, Pyrexia, Blood Fibrinogen Decreased, Fibrin D Dimer Increased, C-Reactive Protein Increased, Blood Alkaline Phosphatase Increased, Viral Infection, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Blood Cholinesterase Decreased, Protein Total Decreased, Local Swelling, Hepatic Enzyme Increased, Varicella Virus Test Positive, Herpes Simplex Serology Positive, Aspartate Aminotransferase Increased, Platelet Count Decreased, Leucine Aminopeptidase Increased, Meningitis Aseptic

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 600mg per day
    Administration route: Oral
    Indication: Bipolar II Disorder

Lamictal
    Dosage: 25mg per day
    Administration route: Oral
    Indication: Bipolar II Disorder
    Start date: 2012-05-07
    End date: 2012-05-23

Other drugs received by patient: Dogmatyl; Desyrel; Magmitt; Clonazepam; Risperdal; Pursennid



Possible Depakene side effects in female

Reported by a physician from Japan on 2012-06-11

Patient: female

Reactions: Eye Discharge, Scab, Pyrexia, LIP Erosion, Generalised Erythema, C-Reactive Protein Increased, Dermatitis Bullous, Monocyte Percentage Increased, Oral Mucosa Erosion, Erythema Multiforme, Eosinophil Percentage Increased, Stevens-Johnson Syndrome, Blister, Erythema of Eyelid, Vulval Disorder, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Toxic Epidermal Necrolysis, Epidermal Necrosis, Ocular Hyperaemia, Aspartate Aminotransferase Increased, Skin Erosion, Rash Maculo-Papular

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 200mg per day
    Administration route: Oral
    Start date: 2011-11-01
    End date: 2012-04-22

Depakene
    Dosage: 100mg per day
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-04-30

Lamictal
    Dosage: 25mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-23
    End date: 2012-04-30

Lamictal
    Dosage: 50mg per day
    Administration route: Oral
    Start date: 2012-05-01
    End date: 2012-05-08

Other drugs received by patient: Zoloft; Cymbalta



Possible Depakene side effects in 16 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-05

Patient: 16 year old female

Reactions: Face Oedema, Lymphadenopathy, Cytolytic Hepatitis, Pyrexia, Rash, Drug Rash With Eosinophilia and Systemic Symptoms, Eosinophilia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-02-16
    End date: 2011-02-22

Depakene
    Administration route: Oral
    Start date: 2011-02-23
    End date: 2011-03-16

Lamotrigine
    Administration route: Oral
    Start date: 2011-03-02
    End date: 2011-03-16

Lamotrigine
    Administration route: Oral
    Start date: 2011-02-23
    End date: 2011-03-01

Lamotrigine
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-02-16
    End date: 2011-02-22



Possible Depakene side effects in female

Reported by a physician from France on 2012-05-31

Patient: female

Reactions: Lymphadenopathy, Pyrexia, Skin Test Positive, Drug Rash With Eosinophilia and Systemic Symptoms, Respiratory Distress, Eosinophilia, Face Oedema, Hepatocellular Injury, Hyperammonaemia, Rash Morbilliform, Rash Maculo-Papular, Leukocytosis, Toxic Skin Eruption, Oxygen Saturation Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-02-16
    End date: 2011-03-16

Lamictal
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-02-16
    End date: 2011-03-16



Possible Depakene side effects in female

Reported by a physician from Japan on 2012-05-25

Patient: female

Reactions: Eye Discharge, Scab, Pyrexia, LIP Erosion, Generalised Erythema, C-Reactive Protein Increased, Dermatitis Bullous, Oral Mucosa Erosion, Erythema Multiforme, Monocyte Percentage Increased, Eosinophil Percentage Increased, Blister, Stevens-Johnson Syndrome, Erythema of Eyelid, Vulval Disorder, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Toxic Epidermal Necrolysis, Aspartate Aminotransferase Increased, Ocular Hyperaemia, Epidermal Necrosis, Skin Erosion, Rash Maculo-Papular

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 200mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-01
    End date: 2012-04-22

Depakene
    Dosage: 100mg per day
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-04-30

Lamictal
    Dosage: 25mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-23
    End date: 2012-04-30

Lamictal
    Dosage: 50mg per day
    Administration route: Oral
    Start date: 2012-05-01
    End date: 2012-05-08

Other drugs received by patient: Zoloft; Cymbalta



Possible Depakene side effects in female

Reported by a physician from France on 2012-05-24

Patient: female

Reactions: Pruritus, Lymphadenopathy, Drug Interaction, Pyrexia, Erythema, Face Oedema, Conjunctival Hyperaemia, Dermatitis Bullous, Skin Disorder, Toxic Epidermal Necrolysis, Vulvar Erosion, Nikolsky's Sign, Mucosal Erosion, Respiratory Tract Congestion, Lacrimation Increased, Rash Maculo-Papular, Toxic Skin Eruption, Keratitis, Inflammation

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2008-12-21
    End date: 2009-04-18

Lamictal
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2009-03-31
    End date: 2009-04-15

Other drugs received by patient: Norlevo; Clobazam



Possible Depakene side effects in 51 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-16

Patient: 51 year old male

Reactions: Tubulointerstitial Nephritis, General Physical Condition Abnormal, Cholestasis, Hypervolaemia, Pyrexia, Renal Hypertrophy, Transaminases Increased, Pericardial Effusion, Nephrotic Syndrome, Ascites, Renal Failure, Glomerulonephritis, Oedema Peripheral, Pleural Effusion, Systemic Inflammatory Response Syndrome, Renal Tubular Necrosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 500 mg, bid
    Administration route: Oral
    End date: 2011-08-01

Keppra
    Dosage: 500 mg, bid
    Administration route: Oral

Tegretol
    Dosage: 400 mg, bid
    Administration route: Oral
    Start date: 2011-08-02
    End date: 2011-11-02



Possible Depakene side effects in 14 year old female

Reported by a individual with unspecified qualification from France on 2012-04-26

Patient: 14 year old female

Reactions: Dilatation Ventricular, Pseudomonas Infection, Pulmonary Arterial Hypertension, Pulmonary Embolism, Pyrexia, Staphylococcal Sepsis, Drug Rash With Eosinophilia and Systemic Symptoms, Prurigo, Toxic Skin Eruption

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: po
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-12-26

Desloratadine
    Dosage: po; po
    Administration route: Oral
    Indication: Rash
    Start date: 2011-12-26

Desloratadine
    Dosage: po; po
    Administration route: Oral
    Indication: Rash
    Start date: 2011-12-03

Lamictal
    Dosage: 100 mg; bid; po, po
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-12-20
    End date: 2011-12-22

Lamictal
    Dosage: 100 mg; bid; po, po
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-11-07
    End date: 2011-12-20

Valium
    Dosage: po
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-12-22

Other drugs received by patient: Prednisolone



Possible Depakene side effects in female

Reported by a physician from Japan on 2012-04-17

Patient: female

Reactions: Drug Eruption, Swelling Face, Rash Generalised, Chills, Pyrexia, Rash, Erythema, Myalgia, Malaise, Generalised Erythema, Erythema Multiforme, Toxic Skin Eruption

Drug(s) suspected as cause:
Depakene
    Dosage: 600mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2012-01-25
    End date: 2012-02-08

Gasmotin
    Dosage: 10mg per day
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2011-08-30

Lamictal
    Dosage: 25mg alternate days
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2012-02-08
    End date: 2012-02-18

Lexapro
    Dosage: 10mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-12-28
    End date: 2012-02-21

Paxil
    Dosage: 20mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-08-30

Rize
    Dosage: 15mg per day
    Administration route: Oral
    Indication: Anxiety
    Start date: 2011-08-30



Possible Depakene side effects in female

Reported by a lawyer from France on 2012-04-11

Patient: female

Reactions: Productive Cough, Weight Decreased, Eyelid Oedema, LIP Disorder, Ulcerative Keratitis, Visual Acuity Reduced, Pyrexia, Oral Mucosal Exfoliation, Blister, Stomatitis, Dysphagia, Mouth Haemorrhage, Toxic Epidermal Necrolysis, Corneal Opacity, Dermal Cyst, Pigmentation LIP, Keratitis, Eye Discharge, Corneal Perforation, Symblepharon, Mouth Ulceration, Conjunctivitis, Fatigue, Skin Discolouration, Photophobia, Iris Incarceration, Rash Papular, Incorrect Dose Administered, Skin Disorder, Hernia, Eye Pain, Mucosal Erosion, Alopecia, Pigmentation Disorder, Itching Scar, Corneal Oedema, Eye Excision, Blindness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 750mg twice per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2008-05-01
    End date: 2010-02-14

Lamictal
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2010-01-19
    End date: 2010-02-13



Possible Depakene side effects in male

Reported by a physician from Japan on 2012-03-28

Patient: male

Reactions: Skin Exfoliation, Eye Discharge, Hyperthermia, Oropharyngeal Pain, Pyrexia, Erythema, Somnolence, LIP Erosion, Cheilitis, Malaise, Conjunctival Hyperaemia, Dizziness, Stevens-Johnson Syndrome, Erythema of Eyelid, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Rash Papular, Rash, Oral Mucosal Erythema, Aspartate Aminotransferase Increased, Epidermal Necrosis, Rash Maculo-Papular

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 400mg per day
    Administration route: Oral
    Indication: Bipolar I Disorder
    Start date: 2011-04-02
    End date: 2011-07-26

Lamictal
    Dosage: 25mg alternate days
    Administration route: Oral
    Indication: Bipolar I Disorder
    Start date: 2011-06-16

Lamictal
    Dosage: 50mg per day
    Administration route: Oral
    End date: 2011-07-19

Other drugs received by patient: Zolpidem; Flunitrazepam; Paxil; Sennoside; Allopurinol; U PAN; Lithium Carbonate; Desyrel



Possible Depakene side effects in 21 year old female

Reported by a consumer/non-health professional from Spain on 2012-03-15

Patient: 21 year old female

Reactions: Rash Erythematous, Drug Interaction, Pyrexia, Respiratory Distress

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Depakene

Other drugs received by patient possibly interacting with the suspect drug:
Lamotrigine
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-20
    End date: 2012-01-22



Possible Depakene side effects in 21 year old female

Reported by a physician from Spain on 2012-03-14

Patient: 21 year old female

Reactions: Vomiting, Nausea, Hypotension, Pyrexia, Respiratory Distress, Menstrual Disorder, Skin Lesion, Rash Erythematous

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-20

Lamictal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-13
    End date: 2012-01-22



Possible Depakene side effects in 23 year old female

Reported by a physician from Japan on 2012-03-07

Patient: 23 year old female

Reactions: Atelectasis, Pneumonia Aspiration, Intentional Overdose, Coma, Laceration, Pyrexia, Intentional Self-Injury, Somnolence, Suicidal Ideation, Anticonvulsant Drug Level Increased, Multiple Drug Overdose Intentional, Sputum Increased, Altered State of Consciousness, Medication Residue, Respiration Abnormal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 4200 mg, unk
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2009-09-11

Lithium Carbonate
    Dosage: 5600 mg, unk
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2009-09-11

Risperdal
    Dosage: 7 mg, unk
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2009-09-11

Tegretol
    Dosage: 4200 mg, daily
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2009-09-11

Other drugs received by patient: Alcohol



Possible Depakene side effects in 29 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-28

Patient: 29 year old male

Reactions: Confusional State, Tachycardia, Pyrexia, Somnolence, Muscle Rigidity, Overdose, Gait Disturbance, Altered State of Consciousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clopixol
    Start date: 2011-11-01

Clopixol
    Indication: Childhood Psychosis
    Start date: 2009-07-01

Depakene
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-13

Lepticur

Lepticur
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-07-01

Nozinan
    Administration route: Oral
    Indication: Childhood Psychosis
    Start date: 2011-11-01

Tranxene
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-23

Trimeprazine Tartrate
    Dosage: 30 drops daily
    Administration route: Oral
    Indication: Childhood Psychosis
    Start date: 2006-07-01

Trimeprazine Tartrate
    Dosage: 30 drops daily
    Administration route: Oral
    Start date: 2011-11-01

Other drugs received by patient: Tercian; Loxapine HCL



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017